Last reviewed · How we verify
NCT05970874
Evaluation of Hand Grip Strength in Pregnant COVID-19 Patients
trial testing Hand grip strength measureme in COVID-19 in 23 participants. Completed in 30 May 2022.
1 May 2022
Quick facts
| Lead sponsor | Karaman Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 1 December 2021 |
| Primary completion | 1 May 2022 |
| Estimated completion | 30 May 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Hand grip strength measureme
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Pregnancy Related — all drugs for Pregnancy Related →
Sponsor
Karaman Training and Research Hospital
Who can join
Eligibility, female only, with COVID-19 or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05970874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Karaman Training and Research Hospital trials
Trials by the same sponsor.
- NCT07130552 — Comparison of Distal IPACK and Popliteal Plexus Block Combined With Femoral Triangle Block After Total Knee Arthroplasty · NA · recruiting
- NCT07102407 — Effect of a Constructivist Educational Program on Preventing Ventilator-Associated Pneumonia in Intensive Care Units · NA · recruiting
- NCT06616740 — Effects of Paratracheal Compression and Cricoid Compression on LMA ProSeal Placement · NA · completed
- NCT06605937 — The Effect of Postoperative Eustachian Milking Maneuver on Eustachian Tube Dysfunction · completed
- NCT06634680 — Effects of Different Parental Involvement on Anxiety and Delirium · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05970874 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karaman Training and Research Hospital
- Last refreshed: 8 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05970874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing